A Study of Persons With Gout Who Do Not Respond to or Are Allergic to Conventional Therapy
Status:
Completed
Trial end date:
2005-02-01
Target enrollment:
Participant gender:
Summary
This is a randomized, open-label, multicenter, parallel-groups study of multiple intravenous
doses of Puricase, administered intravenously, in 40 patients with symptomatic gout. Subjects
must wash out of any uric acid-lowering agents for one week before being dosed, and must
refrain from using such agents throughout the study.